WeChat

Mobile website

2025-4-12- 3

Archive > Volume 19 Issue 6 > 2012,19(6):648-651. DOI:10.3872/j.issn.1007-385X.2012.6.015 Prev Next

Review

Progress of cancer immunotherapy by chimeric antigen receptor-engineered T cells

Article
Figures
Metrics
Preview PDF
Reference
Related
Cited by
Materials

Abstract:

Keywords:

过继细胞免疫治疗 ; 嵌合抗原受体 ; 肿瘤 ; 基因治疗 ; 靶向免疫

Project Supported:

Project supported by National Natural Science Foundation of China (No. 81172415)

您是第497340位访问者
Chinese Journal Of Cancer Biotheray ® 2025 All Rights Reserved
Supported by:Beijing E-Tiller Technology Development Co., Ltd.